Market Tracker

11/26 5:51am ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

97.21
Data as of Nov 25
 +1.03 / +1.07%
Today’s Change
47.03
Today|||52-Week Range
112.57
+51.18%
Year-to-Date

Today’s Trading

Previous close96.18
Today’s open96.18
Day’s range-- - --
Volume510,586
Average volume (3 months)743,193
Market cap$7.4B
Dividend yield--
Data as of 11/25/2014

Growth & Valuation

Earnings growth (last year)+31.28%
Earnings growth (this year)-266.90%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-29.31%
P/E ratioNM
Price/Sales83.91
Price/Book22.68

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+0.16+0.28%
ISISIsis Pharmaceuticals...-0.91-1.74%
CBSTCubist Pharmaceutica...+0.11+0.15%
ICLRICON PLC-0.04-0.07%
Data as of 11/25/2014

Financials

Next reporting dateFebruary 5, 2015
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$47.2M
Annual profit (last year)-$89.2M
Net profit margin-189.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts